Navigation Links
Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies
Date:6/19/2013

PRINCETON, N.J., June 19, 2013 /PRNewswire-iReach/ -- In its first major deal, Belrose Pharma, a new specialty pharmaceutical company dedicated to advancing development of the next generation of innovative injectable and sustained release drug therapies in patient disease populations with high unmet medical needs, today announced the acquisition of Enzon Pharmaceutical's PEGylation Linker Technology (Customized Linker Technology®) platform and associated product pipeline. Acquisition of this technology will enable Belrose Pharma to accelerate creation of improved biologic and small molecule therapies with better treatment outcomes for patients with life-threatening diseases such as breast cancer and pediatric neuroblastoma, and orphan drug diseases such as hereditary angioedema (HAE).    

Through this transaction, Belrose Pharma has added to its portfolio both "traditional" permanent PEGylation and the lesser-known releasable PEGylation technologies, as well as compounds based on both technologies. Polyethylene glycol (PEG), when permanently linked to certain compounds, has a long track record of enabling high-value commercial products through sometimes dramatic improvements in in vivo circulation, toxicity, and efficacy.  The lesser-known releasable PEGylation technique provides a different set of clinical benefits – including several targeted release options without a corresponding reduction in potency, improved drug loading, pharmacokinetics, and efficacy, and a simplified and potentially shorter clinical path to market.

"This acquisition of Enzon's permanent and releasable Customized Linker Technology® significantly strengthens our platform for accelerating the development of more patient-friendly and effective therapies in a range of specialty disease categories," said Belrose Pharma founder and CEO, Eric Gilbert. "We look forward to being a positive
'/>"/>

SOURCE Belrose Pharma Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Omnicell Named Top Vendor in 2013 KLAS Pharmacy Automation Equipment Rankings
2. Pharma IQ Presents the Latest Trends in Clinical Trial Supply
3. Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes
4. Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stock
5. Valeant Pharmaceuticals Prices Public Offering Of Common Shares
6. Though Vital to Educating Doctors on New Products, Pharma "Med Ed" Groups Working Under Huge Internal & External Constraints
7. Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinsons Disease
8. Isis Pharmaceuticals to Present a General Corporate Update at its 2013 Annual Meeting of Stockholders and Open House
9. Valeant Pharmaceuticals Announces Public Offering Of Common Shares
10. Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States
11. Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... , May 22, 2015  The Mesothelioma Victims ... victims of mesothelioma get the best possible compensation, ... individuals with this rare cancer caused by exposure ... up-to-date information related to treatment options such as ... call the Mesothelioma Victims Center anytime at 866-714-6466. ...
(Date:5/22/2015)... 20, 2015 Research and Markets( http://www.researchandmarkets.com/research/28m7nx/guide_to_prepare ... "Guide to Prepare Application Dossiers for Oversea Medical ... " report to their offering. ... segment market of the most growth potentiality, which ... manufacturers and producers to penetrate such market. It ...
(Date:5/22/2015)... , May 22, 2015 Research and Markets ... addition of the "Latest Regulations on Pharmaceutical ... to their offering. This is first ... a guidance on international multi-center clinical trials of ... has begun to be implemented on March 1, ...
Breaking Medicine Technology:Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 2Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 4Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 5China Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation 2China Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation 32015 Regulations on Pharmaceutical International Multi-Center Clinical Trials in China 2
... DIEGO, April 14, 2011 LifeVantage Corporation (OTCBB: ... preliminary net revenue for its third fiscal quarter of 2011 ... $2.6 million or 35% over net revenue of $7.4 million ... is also an approximate $7.3 million or 270% increase in ...
... Attorney General Roy Cooper warned the House Special Select ... immunity to pharmaceutical companies could cost North Carolina taxpayers ... dollars." Still, the GOP-controlled committee, led by ... could go to the House floor for a vote ...
Cached Medicine Technology:LifeVantage Announces Preliminary Third Quarter 2011 Revenue 2GOP's Big Pharma Protection to Cost NC Taxpayers "Hundreds of Millions" 2
(Date:5/24/2015)... 24, 2015 ... - The students were selected ... the fourth annual A Day of ... Geneva National in Lake Geneva. , ... High School,         Jonathan Alfonso,         Bridget Keefe, ...
(Date:5/23/2015)... (PRWEB) May 23, 2015 With the ... businesses, are finding it increasingly difficult to provide their ... fail to provide adequate insurance for employees stand to ... been such an integral part of a business’s success ... healthcare for businesses, Online USA Doctors has created a ...
(Date:5/23/2015)... Javon Bea Mercy Health System CEO ... Center, 557 N. Washington St., Janesville, will host an ... pm. , The 8-week clinic is lead by Brent ... who will offer training that encompasses a warm-up, training ... show selection and weekly training plans. , The program ...
(Date:5/22/2015)... The American College of Traditional Chinese ... They will hold a webinar on the updates of ... on Classical Chinese Medicine. , Webinar – First Professional ... the Dean of Clinical Education, will lead this webinar ... Doctorate program. ACTCM is currently developing this degree program ...
(Date:5/22/2015)... May 22, 2015 Omar Ahmad Barrada, ... to participate in the 2015 Congress of Future Medical ... as a gathering of “America’s highest achieving high school ... of healthcare, set new goals and learn better study ... live surgery, during which we can ask the surgeons ...
Breaking Medicine News(10 mins):Health News:Mercy Foundation Honors 16 Students for Making a Difference - Mercy Health System Javon Bea 2Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 2Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 3Health News:ACTCM Announces Upcoming June Events 2Health News:Milton Hershey School Student Chosen for Congress of Future Medical Leaders 2
... Amanda Gardner HealthDay Reporter , TUESDAY, Nov. 16 ... defective one, scientists were able to partially restore the heart,s ... "This is the first time gene therapy has been ... heart failure," study lead author Dr. Donna Mancini, professor of ...
... prescription filled can undermine medical treatment, result in increased ... the patient. An editorial in the Nov. 16 issue ... the problem and issues a call to action. ... Nonadherence," Michael D. Murray, PharmD, MPH, a Regenstrief Institute, ...
... HealthDay Reporter , MONDAY, Nov. 15 (HealthDay News) ... those involved: Sometimes surgical instruments and sponges are left inside ... Children suffering from such mishaps were not more likely ... are more than twice as long and cost more than ...
... 1 and 1-1/2, children who get most of their sleep at ... variety of skill areas than children who don,t sleep as much ... conducted by researchers at the University of Montreal and the University ... the journal Child Development . The study, of 60 ...
... cancer appear more likely to experience hearing loss and to ... not receive such treatment, according to a report in the ... , one of the JAMA/Archives journals. Head and neck ... according to background information in the article. Treatment methods include ...
... MONDAY, Nov. 15 (HealthDay News) -- In Australia, where universal ... much more prevalent among poor citizens than it is among ... researchers say that differences in risk do exist between the ... heart disease is typically thought of as more prevalent in ...
Cached Medicine News:Health News:Gene Therapy Shows Potential Against Heart Failure 2Health News:Not following doctor's orders: Prescription abandonment 2Health News:Sponges, Surgical Tools Sometimes Left in Kids After Operation 2Health News:Sponges, Surgical Tools Sometimes Left in Kids After Operation 3Health News:Nighttime sleep found beneficial to infants' skills 2Health News:Hearing loss common following radiation therapy for head and neck cancer 2Health News:Universal Health Care May Lessen Income's Impact on Heart Disease 2
... Catheter is indicated for balloon ... of a coronary artery or ... purpose of improving myocardial perfusion. ... also designed to provide distal ...
16mm from Mid-screw to Tips, blunt tips; overall length 110mm; Stainless Steel...
Angled 45 Degrees to Right, 9.5mm blade, gently curved .5x .25mm blunt tips; Lower blade is 0.5mm longer; 14mm from mid screw to tip; (Available in left and right; ) overall length 120mm; Stainless ...
Two prong stainless steel tips; with titanium handle/...
Medicine Products: